{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:32:24Z","timestamp":1788895944773,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH113572"],"award-info":[{"award-number":["R01MH113572"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH113572"],"award-info":[{"award-number":["R01MH113572"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH113572"],"award-info":[{"award-number":["R01MH113572"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH113572"],"award-info":[{"award-number":["R01MH113572"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH113572"],"award-info":[{"award-number":["R01MH113572"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R00 MH121166"],"award-info":[{"award-number":["R00 MH121166"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R00 MH121166"],"award-info":[{"award-number":["R00 MH121166"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R00 MH121166"],"award-info":[{"award-number":["R00 MH121166"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R00 MH121166"],"award-info":[{"award-number":["R00 MH121166"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R00 MH121166"],"award-info":[{"award-number":["R00 MH121166"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cost remains an important barrier to HIV pre-exposure prophlyaxis (PrEP) delivery in Africa. Simplified delivery models that reduce costs without compromising PrEP outcomes are needed. The JiPime-JiPrEP trial tested a model of six-month PrEP dispensing supported with interim HIV self-testing (HIVST) and found non-inferior HIV testing, PrEP refilling, and adherence compared to three-month PrEP dispensing and quarterly clinic visits, the standard-of-care (SOC). We estimated the cost of this novel differentiated PrEP delivery model compared to SOC in Kenya.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using activity-based micro-costing (payer perspective) and time-and-motion observations, we estimated the cost of PrEP delivery (per client-month) in the intervention and SOC between May 2018 to December 2019. Data from budgets and expense reports, published documents, and interviews informed our estimates. We calculated costs over a one-year horizon for: 1) the <jats:italic>trial scenario<\/jats:italic> (i.e., costs within the trial), and 2) the <jats:italic>Ministy of Health (MOH) scenario<\/jats:italic> (i.e., hypothetical costs at public clinics). Estimates were in 2019 US dollars and excluded research-related costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean personnel time attributable to PrEP delivery was 76 minutes per visit and 152 minutes projected over a year in the intervention and 54 minutes per visit and 282 minutes per year in the SOC. In the trial scenario, PrEP delivery cost $17.73 per client-month in the intervention (n=2039 PrEP-months) and $25.50 in the SOC (n=913 PrEP-months). The projected cost of PrEP delivery in the MOH scenario was $11.94 in the intervention and $14.76 in the SOC, with the addition of HIVST kits in the intervention more than offset by personnel savings. In this scenario, personnel (intervention: 55%; SOC: 44%) and medication (intervention: 16%; SOC: 32%) were the primary cost drivers. Including serum creatine testing twice a year in the MOH scenario resulted in a slight increase in the cost of PrEP delivery in the intervention ($12.88 per client-month) versus SOC ($16.17 per client-month).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Six-month PrEP with interim HIVST demonstrated lower costs than three-month dispensing, with decreased personnel time. Scale-up of PrEP delivery requires efficient use of limited resources; the savings in this model of PrEP delivery could be redirected towards currently unmet medical needs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinial trial number<\/jats:title>\n            <jats:p>NCT03593629||<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/\" ext-link-type=\"uri\">https:\/\/www.clinicaltrials.gov\/<\/jats:ext-link> with the Clinical Trial Registry (Registration date: 2018-07-20).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12913-025-12891-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:51:49Z","timestamp":1751377909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Opportunity for cost savings with a novel differentiated model of PrEP delivery: a comparative costing analysis of six-month PrEP supported by interim HIV self-testing and standard of care PrEP dispensing in Kenya"],"prefix":"10.1186","volume":"25","author":[{"given":"Dorothy I.","family":"Mangale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Heitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina F.","family":"Ortblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mogere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kiptinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly R.","family":"Mugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ngure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruanne","family":"Barnabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"4 Suppl 3","key":"12891_CR1","doi-asserted-by":"publisher","first-page":"20227","DOI":"10.7448\/IAS.18.4.20227","volume":"18","author":"CL Celum","year":"2015","unstructured":"Celum CL, et al. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. J Int AIDS Soc. 2015;18(4 Suppl 3):20227.","journal-title":"J Int AIDS Soc."},{"key":"12891_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11904-019-00437-6","volume":"6","author":"G O\u2019Malley","year":"2019","unstructured":"O\u2019Malley G, Barnabee G, Mugwanya K. Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART? Current HIV\/AIDS Rep. 2019;6:141\u201350. https:\/\/doi.org\/10.1007\/s11904-019-00437-6.","journal-title":"Current HIV\/AIDS Rep"},{"issue":"1","key":"12891_CR3","doi-asserted-by":"publisher","first-page":"21484","DOI":"10.7448\/IAS.19.1.21484","volume":"19","author":"A Grimsrud","year":"2016","unstructured":"Grimsrud A, et al. Reimagining HIV service delivery: The role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016;19(1):21484. https:\/\/doi.org\/10.7448\/IAS.19.1.21484.","journal-title":"J Int AIDS Soc"},{"key":"12891_CR4","doi-asserted-by":"publisher","unstructured":"Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, Futterman D. Shifting the Paradigm in HIV Prevention and Treatment Service Delivery Toward Differentiated Care for Youth. NAM Perspectives. 2019. https:\/\/doi.org\/10.31478\/201903a.","DOI":"10.31478\/201903a"},{"issue":"Suppl 2","key":"12891_CR5","doi-asserted-by":"publisher","first-page":"e26095","DOI":"10.1002\/jia2.26095","volume":"26 Suppl 2","author":"A Grimsrud","year":"2023","unstructured":"Grimsrud A, et al. The importance of the \u201chow\u201d: the case for differentiated service delivery of long-acting and extended delivery regimens for HIV prevention and treatment. J Int AIDS Soc. 2023;26 Suppl 2(Suppl 2):e26095. https:\/\/doi.org\/10.1002\/jia2.26095.","journal-title":"J Int AIDS Soc."},{"issue":"Suppl 4","key":"12891_CR6","doi-asserted-by":"publisher","first-page":"21648","DOI":"10.7448\/IAS.20.5.21648","volume":"20","author":"C Barker","year":"2017","unstructured":"Barker C, Dutta A, Klein K. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa. J Int AIDS Soc. 2017;20(Suppl 4):21648.","journal-title":"J Int AIDS Soc."},{"issue":"5","key":"12891_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41591-020-0872-x","volume":"26","author":"EM Irungu","year":"2020","unstructured":"Irungu EM, Baeten JM. PrEP rollout in Africa: status and opportunity. Nat Med. 2020;26(5):655\u201364. https:\/\/doi.org\/10.1038\/s41591-020-0872-x.","journal-title":"Nat Med."},{"issue":"10","key":"12891_CR8","doi-asserted-by":"publisher","first-page":"e0259738","DOI":"10.1371\/journal.pone.0259738","volume":"17","author":"K Atkins","year":"2022","unstructured":"Atkins K, et al. Health system opportunities and challenges for PrEP implementation in Kenya: A qualitative framework analysis. PLoS One. 2022;17(10):e0259738.","journal-title":"PLoS One."},{"issue":"1","key":"12891_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/QCO.0000000000000511","volume":"32","author":"N Ahmed","year":"2019","unstructured":"Ahmed N, Pike C, Bekker LG. Scaling up pre-exposure prophylaxis in sub-Saharan Africa. Curr Opin Infect Dis. 2019;32(1):24\u201330. https:\/\/doi.org\/10.1097\/QCO.0000000000000511.","journal-title":"Curr Opin Infect Dis."},{"issue":"1","key":"12891_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/COH.0000000000000224","volume":"11","author":"NR Mugo","year":"2016","unstructured":"Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N. The preexposure prophylaxis revolution; From clinical trials to programmatic implementation. Curr Opin HIV AIDS. 2016;11(1):80\u20136. https:\/\/doi.org\/10.1097\/COH.0000000000000224.","journal-title":"Curr Opin HIV AIDS."},{"issue":"1","key":"12891_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12981-023-00535-x","volume":"20","author":"JJ Chebet","year":"2023","unstructured":"Chebet JJ, et al. Motivations for pre-exposure prophylaxis uptake and decline in an HIV-hyperendemic setting: findings from a qualitative implementation study in Lesotho. AIDS Res Ther. 2023;20(1):43.","journal-title":"AIDS Res Ther."},{"issue":"1","key":"12891_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jia2.25619","volume":"23","author":"KF Ortblad","year":"2020","unstructured":"Ortblad KF, Mogere P, Bukusi E, Ngure K, Baeten JM. Pharmacy delivery to expand the reach of PrEP in Africa. J Int AIDS Soc. 2020;23(1):43. https:\/\/doi.org\/10.1002\/jia2.25619.","journal-title":"J Int AIDS Soc."},{"issue":"1","key":"12891_CR13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1186\/s12913-020-05898-9","volume":"20","author":"KF Ortblad","year":"2020","unstructured":"Ortblad KF, et al. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation. BMC Health Serv Res. 2020;20(1):1034.","journal-title":"BMC Health Serv Res."},{"issue":"1","key":"12891_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13063-019-3521-2","volume":"20","author":"KF Ortblad","year":"2019","unstructured":"Ortblad KF, et al. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: A randomized trial in Kenya. Trials. 2019;20(1):396.","journal-title":"Trials."},{"issue":"4","key":"12891_CR15","doi-asserted-by":"publisher","first-page":"e25261","DOI":"10.1002\/jia2.25261","volume":"22","author":"R Heffron","year":"2019","unstructured":"Heffron R, et al. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness. J Int AIDS Soc. 2019;22(4):e25261.","journal-title":"J Int AIDS Soc."},{"key":"12891_CR16","doi-asserted-by":"crossref","unstructured":"Heffron R, et al. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: Uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Res. 2017;1:3.","DOI":"10.12688\/gatesopenres.12752.1"},{"issue":"1","key":"12891_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13012-018-0809-7","volume":"13","author":"KK Mugwanya","year":"2018","unstructured":"Mugwanya KK, et al. Scale up of PrEP integrated in public health HIV care clinics: A protocol for a stepped-wedge cluster-randomized rollout in Kenya. Implement Sci. 2018;13(1):118.","journal-title":"Implement Sci."},{"issue":"8","key":"12891_CR18","doi-asserted-by":"publisher","first-page":"e1002099","DOI":"10.1371\/journal.pmed.1002099","volume":"13","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, et al. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1\u2013Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda. PLoS Med. 2016;13(8):e1002099.","journal-title":"PLoS Med."},{"issue":"9","key":"12891_CR19","doi-asserted-by":"publisher","first-page":"e1002885","DOI":"10.1371\/journal.pmed.1002885","volume":"16","author":"KK Mugwanya","year":"2019","unstructured":"Mugwanya KK, et al. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya. PLoS Med. 2019;16(9):e1002885.","journal-title":"PLoS Med."},{"issue":"3","key":"12891_CR20","doi-asserted-by":"publisher","first-page":"e025122","DOI":"10.1136\/bmjopen-2018-025122","volume":"9","author":"JC Dettinger","year":"2019","unstructured":"Dettinger JC, et al. PrEP Implementation for Mothers in Antenatal Care (PrIMA): Study protocol of a cluster randomised trial. BMJ Open. 2019;9(3):e025122.","journal-title":"BMJ Open."},{"key":"12891_CR21","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/S2352-3018(19)30335-2","volume":"7","author":"J Kinuthia","year":"2020","unstructured":"Kinuthia J, et al. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme. Lancet HIV. 2020;7:e38\u201348.","journal-title":"Lancet HIV"},{"key":"12891_CR22","doi-asserted-by":"crossref","unstructured":"Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N. PrEP for Africa: What we have learnt and what is needed to move to program implementation. Curr Opin HIV AIDS. 2016;11(1):80.","DOI":"10.1097\/COH.0000000000000224"},{"issue":"4","key":"12891_CR23","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s10508-020-01880-y","volume":"50","author":"R Muhumuza","year":"2021","unstructured":"Muhumuza R, et al. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa. Arch Sex Behav. 2021;50(4):1729\u201342.","journal-title":"Arch Sex Behav."},{"key":"12891_CR24","doi-asserted-by":"crossref","unstructured":"Irungu EM, et al. The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya. AIDS Res Treat. 2019;2019:4170615.","DOI":"10.1155\/2019\/4170615"},{"key":"12891_CR25","doi-asserted-by":"publisher","unstructured":"Roberts E, et al. Low program access despite high burden of sexual, structural, and reproductive health vulnerabilities among young women who sell sex in Mombasa. Kenya BMC Public Health. 2020. https:\/\/doi.org\/10.1186\/s12889-020-08872-6.","DOI":"10.1186\/s12889-020-08872-6"},{"key":"12891_CR26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/aid.2017.0187","volume":"34","author":"K Peebles","year":"2018","unstructured":"Peebles K, et al. Low costs and opportunities for efficiency in the first year of programmatic PrEP delivery in Kenya\u2019s public sector. AIDS Res Hum Retroviruses. 2018;34:269.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"12891_CR27","doi-asserted-by":"publisher","first-page":"e0249625","DOI":"10.1371\/journal.pone.0249625","volume":"16","author":"V Wanga","year":"2021","unstructured":"Wanga V, et al. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in kisumu, Kenya. PLoS One. 2021;16(4):e0249625.","journal-title":"PLoS One."},{"issue":"Suppl Suppl 4","key":"12891_CR28","doi-asserted-by":"publisher","first-page":"e25296","DOI":"10.1002\/jia2.25296","volume":"22 Suppl 4","author":"DA Roberts","year":"2019","unstructured":"Roberts DA, et al. The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya. J Int AIDS Soc. 2019;22 Suppl 4(Suppl Suppl 4):e25296.","journal-title":"J Int AIDS Soc."},{"key":"12891_CR29","unstructured":"WHO. Current health expenditure per capita (current US$) - Kenya. World Health Organization Global Health Expenditure database. 2022. https:\/\/data.worldbank.org\/indicator\/SH.XPD.CHEX.PC.CD?end=2019&locations=KE&start=2000&view=map."},{"key":"12891_CR30","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/S2352-3018(22)00126-6","volume":"9","author":"K Ngure","year":"2022","unstructured":"Ngure K, et al. Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial. Lancet HIV. 2022;9:e464\u201373.","journal-title":"Lancet HIV"},{"key":"12891_CR31","unstructured":"National AIDS and STI Control Programme (NASCOP), Ministry of Health. \u201cKenya Population Based HIV Impact Assessment (KENPHIA) 2018 Preliminary Report\u201d. Nairobi: NASCOP; 2020."},{"key":"12891_CR32","doi-asserted-by":"crossref","unstructured":"Ngure K, Ortblad KO, Mogere P, Thomas K, Mangale D, Kiptinness C, Gakuo S, Mbaire S, Nyokabi J, Bardon RA, Mugo NR, Baeten J. Six-month PrEP dispensing with HIV self-testing to improve the efficiency of delivery in Kenya: a randomized implementation trial. Lancet HIV. 2021;9(7):e464.","DOI":"10.1016\/S2352-3018(22)00126-6"},{"key":"12891_CR33","unstructured":"National AIDS & STI Control Programme (NASCOP), Ministry of Health. \u201cFramework for the Implementation of Pre-exposure Prophylaxis of HIV in Kenya\u201d. Nairobi; 2022. p. 1\u2013134."},{"key":"12891_CR34","unstructured":"Rosen JE, Plosky WD, Bollinger L. Guidelines for Costing of Social and Behavior Change Health Interventions: Breakthrough Research. Washington, DC: Population Council; 2019. https:\/\/knowledgecommons.popcouncil.org\/cgi\/viewcontent.cgi?article=2304&context=departments_sbsr-pgy. Accessed 5 May 2021."},{"key":"12891_CR35","unstructured":"Kumaranayake L, Pepperall J, Goodman H, Mills A, Walker D. Costing Guidelines for HIV Prevention Strategies. Geneva: Joint United Nations Program on HIV\/AIDS (UNAIDS); 2000. https:\/\/data.unaids.org\/publications\/irc-pub05\/jc412-costguidel_en.pdf. Accessed 5 May 2021."},{"key":"12891_CR36","unstructured":"Public Procurement Regulatory Authority (PPRA). \u201cMarket Price Index\u201d. Nairobi; 2013. https:\/\/ppra.go.ke\/market-price-index\/. Accessed 12 Dec 2021."},{"key":"12891_CR37","unstructured":"Nairobi County. The Government Printer. Nairobi City County Gazette Supplement.\" No.7 (Acts No. 2). Nairobi: The Government Printer; 2014. https:\/\/kenyalaw.org\/kl\/fileadmin\/pdfdownloads\/Acts\/NairobiCityCountyWardsDevelopmentFundAmendmentAct2014.pdf. Accessed 20 May 2021."},{"key":"12891_CR38","unstructured":"Central Bank of Kenya. Forex Rates. Nairobi; 2019. https:\/\/www.centralbank.go.ke\/forex\/."},{"key":"12891_CR39","unstructured":"National AIDS & STI Control Programme (NASCOP), Ministry of Health. Guidelines on use of antiretroviral drugs for treating and preventing HIV infection in Kenya. Nairobi: NASCOP; 2018. https:\/\/cquin.icap.columbia.edu\/wp-content\/uploads\/2017\/04\/ICAP_CQUIN_Kenya-ARV-Guidelines-2018-Final_20thAug2018.pdf. Accessed 20 June 2020."},{"issue":"3","key":"12891_CR40","doi-asserted-by":"publisher","first-page":"e1001401","DOI":"10.1371\/journal.pmed.1001401","volume":"10","author":"GB Gomez","year":"2013","unstructured":"Gomez GB, et al. The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies. PLoS Med. 2013;10(3):e1001401. Preprint at\u00a0https:\/\/doi.org\/10.1371\/journal.pmed.1001401.","journal-title":"PLoS Med."},{"key":"12891_CR41","doi-asserted-by":"publisher","first-page":"e2077","DOI":"10.1371\/journal.pone.0002077","volume":"3","author":"DCJ Vissers","year":"2008","unstructured":"Vissers DCJ, Voeten HACM, Nagelkerke NJD, Habbema JDF, de Vlas SJ. The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: A simulation study. PLoS One. 2008;3:e2077.","journal-title":"PLoS One."},{"issue":"7","key":"12891_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. New Engl J Med. 2021;385(7):595\u2013608.","journal-title":"New Engl J Med."},{"key":"12891_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00365-4","author":"J Smith","year":"2023","unstructured":"Smith J, et al. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Lancet HIV. 2023. https:\/\/doi.org\/10.1016\/S2352-3018(22)00365-4.","journal-title":"Lancet HIV"},{"key":"12891_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0258542","volume":"16","author":"E Rousseau","year":"2021","unstructured":"Rousseau E, et al. Adolescent girls and young women\u2019s PrEP-user journey during an implementation science study in South Africa and Kenya. PLoS One. 2021;16:1\u201318.","journal-title":"PLoS One"},{"key":"12891_CR45","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11904-022-00617-x","volume":"19","author":"C Kiptinness","year":"2022","unstructured":"Kiptinness C, et al. Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review. Curr HIV\/AIDS Rep. 2022;19:394\u2013408.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"12891_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10461-021-03480-w","volume":"26","author":"C Mangenah","year":"2022","unstructured":"Mangenah C, et al. Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe. AIDS Behav. 2022;26:171. https:\/\/doi.org\/10.1007\/s10461-021-03480-w.","journal-title":"AIDS Behav"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12891-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12891-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12891-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:51:53Z","timestamp":1751377913000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-12891-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12891"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12891-7","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved as a minimal risk study by the Scientific and Ethics Review Unit of the Kenya Medical Research Institute and the Human Subjects Division of the University of Washington. PrEP clients who participated in structured interviews provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JMB is an employee of Gilead Sciences, outside of this work. The other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"865"}}